Patent ID: 11859254
Assignee: EXACT SCIENCES CORPORATION
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 1:
2. The method of claim 1,
wherein the primers specific for ELMO1 are capable of binding an amplicon bound by SEQ ID Nos: 7 and 8 or SEQ ID Nos: 21 and 22 or SEQ ID Nos: 80 and 81;
wherein the primers specific for ZNF569 are capable of binding an amplicon bound by SEQ ID Nos: 11 and 12 or SEQ ID Nos: 86 and 87;
wherein the primers specific for C13orf18 are capable of binding an amplicon bound by SEQ ID Nos: 19 and 20 or SEQ ID Nos: 74 and 75;
wherein the primers specific for CD1D are capable of binding an amplicon bound by SEQ ID Nos: 3 or 4 or SEQ ID Nos: 39 and 40 or SEQ ID Nos: 98 and 99;
wherein the primers specific for ARHGEF4 are capable of binding an amplicon bound by SEQ ID Nos: 17 and 18 or SEQ ID Nos: 23 and 24 or SEQ ID Nos: 95 and 96;
wherein the primers specific for SFMBT2 are capable of binding an amplicon bound by SEQ ID Nos: 5 and 6 or SEQ ID Nos: 83 and 84;
wherein the primers specific for PPP2R5C are capable of binding an amplicon bound by SEQ ID Nos: 61 and 62 or SEQ ID Nos: 92 and 93;
wherein the primers specific for CYP26C1 are capable of binding an amplicon bound by SEQ ID Nos: 15 and 16 or SEQ ID Nos: 43 and 44 or SEQ ID Nos: 104 and 105;
wherein the primers specific for PKIA are capable of binding an amplicon bound by SEQ ID Nos: 49 and 50 or SEQ ID Nos: 71 and 72;
wherein the primers specific for CLEC11A are capable of binding an amplicon bound by SEQ ID Nos: 1 and 2 or SEQ ID Nos: 29 and 30 or SEQ ID Nos: 77 and 78; and
wherein the primers specific for LRRC4 are capable of binding an amplicon bound by SEQ ID Nos: 107 and 108;
wherein the primers specific for ST8SIA1 are capable of binding an amplicon bound by SEQ ID Nos: 13 and 14 or SEQ ID Nos: 101 and 102; and
wherein the primers specific for NDRG4 are capable of binding an amplicon bound by SEQ ID Nos: 57 and 58.